Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS
Major depressive disorder is a psychiatric disease having approximately a 20% lifetime prevalence in adults in the United States (U.S.), as reported by Hasin et al. in <i>JAMA Psichiatry</i> 2018 <i>75</i>, 336−346. Symptoms include low mood, anhedonia, decreased en...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/9/17/3631 |
id |
doaj-9caf4eec54af4eff8504dc8925e656bf |
---|---|
record_format |
Article |
spelling |
doaj-9caf4eec54af4eff8504dc8925e656bf2020-11-24T21:26:47ZengMDPI AGApplied Sciences2076-34172019-09-01917363110.3390/app9173631app9173631Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROSCecilia Muraro0Marco Dalla Tiezza1Chiara Pavan2Giovanni Ribaudo3Giuseppe Zagotto4Laura Orian5Department of Chemical Sciences, University of Padova, Via Marzolo 1, 35131 Padova, ItalyDepartment of Chemical Sciences, University of Padova, Via Marzolo 1, 35131 Padova, ItalyDepartment of Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, ItalyDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, ItalyDepartment of Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131 Padova, ItalyDepartment of Chemical Sciences, University of Padova, Via Marzolo 1, 35131 Padova, ItalyMajor depressive disorder is a psychiatric disease having approximately a 20% lifetime prevalence in adults in the United States (U.S.), as reported by Hasin et al. in <i>JAMA Psichiatry</i> 2018 <i>75</i>, 336−346. Symptoms include low mood, anhedonia, decreased energy, alteration in appetite and weight, irritability, sleep disturbances, and cognitive deficits. Comorbidity is frequent, and patients show decreased social functioning and a high mortality rate. Environmental and genetic factors favor the development of depression, but the mechanisms by which stress negatively impacts on the brain are still not fully understood. Several recent works, mainly published during the last five years, aim at investigating the correlation between treatment with fluoxetine, a non-tricyclic antidepressant drug, and the amelioration of oxidative stress. In this work, the antioxidant activity of fluoxetine was investigated using a computational protocol based on the density functional theory approach. Particularly, the scavenging of five radicals (HO<sup>•</sup>, HOO<sup>•</sup>, CH<sub>3</sub>OO<sup>•</sup>, CH<sub>2</sub>=CHOO<sup>•</sup>, and CH<sub>3</sub>O<sup>•</sup>) was considered, focusing on hydrogen atom transfer (HAT) and radical adduct formation (RAF) mechanisms. Thermodynamic as well as kinetic aspects are discussed, and, for completeness, two metabolites of fluoxetine and serotonin, whose extracellular concentration is enhanced by fluoxetine, are included in our analysis. Indeed, fluoxetine may act as a radical scavenger, and exhibits selectivity for HO<sup>•</sup> and CH<sub>3</sub>O<sup>•</sup>, but is inefficient toward peroxyl radicals. In contrast, the radical scavenging efficiency of serotonin, which has been demonstrated in vitro, is significant, and this supports the idea of an indirect antioxidant efficiency of fluoxetine.https://www.mdpi.com/2076-3417/9/17/3631free radical scavengersantioxidantsfluoxetinedepressive disordermajoroxidative stressDFT calculationsreactive oxygen species |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cecilia Muraro Marco Dalla Tiezza Chiara Pavan Giovanni Ribaudo Giuseppe Zagotto Laura Orian |
spellingShingle |
Cecilia Muraro Marco Dalla Tiezza Chiara Pavan Giovanni Ribaudo Giuseppe Zagotto Laura Orian Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS Applied Sciences free radical scavengers antioxidants fluoxetine depressive disorder major oxidative stress DFT calculations reactive oxygen species |
author_facet |
Cecilia Muraro Marco Dalla Tiezza Chiara Pavan Giovanni Ribaudo Giuseppe Zagotto Laura Orian |
author_sort |
Cecilia Muraro |
title |
Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS |
title_short |
Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS |
title_full |
Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS |
title_fullStr |
Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS |
title_full_unstemmed |
Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS |
title_sort |
major depressive disorder and oxidative stress: in silico investigation of fluoxetine activity against ros |
publisher |
MDPI AG |
series |
Applied Sciences |
issn |
2076-3417 |
publishDate |
2019-09-01 |
description |
Major depressive disorder is a psychiatric disease having approximately a 20% lifetime prevalence in adults in the United States (U.S.), as reported by Hasin et al. in <i>JAMA Psichiatry</i> 2018 <i>75</i>, 336−346. Symptoms include low mood, anhedonia, decreased energy, alteration in appetite and weight, irritability, sleep disturbances, and cognitive deficits. Comorbidity is frequent, and patients show decreased social functioning and a high mortality rate. Environmental and genetic factors favor the development of depression, but the mechanisms by which stress negatively impacts on the brain are still not fully understood. Several recent works, mainly published during the last five years, aim at investigating the correlation between treatment with fluoxetine, a non-tricyclic antidepressant drug, and the amelioration of oxidative stress. In this work, the antioxidant activity of fluoxetine was investigated using a computational protocol based on the density functional theory approach. Particularly, the scavenging of five radicals (HO<sup>•</sup>, HOO<sup>•</sup>, CH<sub>3</sub>OO<sup>•</sup>, CH<sub>2</sub>=CHOO<sup>•</sup>, and CH<sub>3</sub>O<sup>•</sup>) was considered, focusing on hydrogen atom transfer (HAT) and radical adduct formation (RAF) mechanisms. Thermodynamic as well as kinetic aspects are discussed, and, for completeness, two metabolites of fluoxetine and serotonin, whose extracellular concentration is enhanced by fluoxetine, are included in our analysis. Indeed, fluoxetine may act as a radical scavenger, and exhibits selectivity for HO<sup>•</sup> and CH<sub>3</sub>O<sup>•</sup>, but is inefficient toward peroxyl radicals. In contrast, the radical scavenging efficiency of serotonin, which has been demonstrated in vitro, is significant, and this supports the idea of an indirect antioxidant efficiency of fluoxetine. |
topic |
free radical scavengers antioxidants fluoxetine depressive disorder major oxidative stress DFT calculations reactive oxygen species |
url |
https://www.mdpi.com/2076-3417/9/17/3631 |
work_keys_str_mv |
AT ceciliamuraro majordepressivedisorderandoxidativestressinsilicoinvestigationoffluoxetineactivityagainstros AT marcodallatiezza majordepressivedisorderandoxidativestressinsilicoinvestigationoffluoxetineactivityagainstros AT chiarapavan majordepressivedisorderandoxidativestressinsilicoinvestigationoffluoxetineactivityagainstros AT giovanniribaudo majordepressivedisorderandoxidativestressinsilicoinvestigationoffluoxetineactivityagainstros AT giuseppezagotto majordepressivedisorderandoxidativestressinsilicoinvestigationoffluoxetineactivityagainstros AT lauraorian majordepressivedisorderandoxidativestressinsilicoinvestigationoffluoxetineactivityagainstros |
_version_ |
1725977549910048768 |